- NCIt
- C8101
Loading cancer entity…
Loading cancer entity…
Clinical trials
1,164 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00084708 | Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 53 | Roswell Park Cancer InstituteOTHER | 1 | Jan 13, 2014 | clinicaltrials |
| NCT00112892 | Irinotecan and Selenium in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 36 | Roswell Park Cancer InstituteOTHER | 1 | Jan 13, 2014 | clinicaltrials |
| NCT00003768 | Combretastatin A4 Phosphate in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 25 | Case Comprehensive Cancer CenterOTHER | 1 | Jan 7, 2014 | clinicaltrials |
| NCT00769288 | FAU in Treating Patients With Advanced Solid Tumors or Lymphoma | completed | Phase 1 | 12 | National Cancer Institute (NCI)NIH | 1 | Jan 7, 2014 | clinicaltrials |
| NCT00004979 | Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid Tumors | completed | Phase 1 / Phase 2 | — | Jonsson Comprehensive Cancer CenterOTHER | 0 | Jan 6, 2014 | clinicaltrials |
| NCT00003697 | Dimethylxanthenone Acetic Acid in Treating Patients With Solid Tumors | completed | Phase 1 | 3 | University of GlasgowOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00003698 | Chemotherapy in Treating Patients With Solid Tumors | completed | Phase 1 | 35 | University of GlasgowOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00004051 | Irinotecan in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 40 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00005791 | Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00008073 | Octreotide and Doxorubicin in Treating Patients With Advanced Cancer | completed | Phase 1 | — | University of PittsburghOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00008086 | Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | University of PittsburghOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00009802 | Calcitriol Plus Paclitaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 45 | University of PittsburghOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00072332 | Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00017524 | AG2037 in Treating Patients With Advanced, Metastatic, or Recurrent Solid Tumors | completed | Phase 1 | 22 | University of Alabama at BirminghamOTHER | 1 | Dec 16, 2013 | clinicaltrials |
| NCT00080990 | Alvocidib, Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 46 | National Cancer Institute (NCI)NIH | 1 | Dec 16, 2013 | clinicaltrials |
| NCT00243100 | Vorinostat and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 21 | National Cancer Institute (NCI)NIH | 1 | Dec 16, 2013 | clinicaltrials |
| NCT00390052 | 3-AP in Treating Patients With Advanced or Metastatic Solid Tumors | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Dec 16, 2013 | clinicaltrials |
| NCT00007878 | Bortezomib, Fluorouracil, and Leucovorin Calcium in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Dec 11, 2013 | clinicaltrials |
| NCT00021073 | Combination Chemotherapy in Treating Patients With Advanced Cancer | completed | Phase 1 | 90 | National Cancer Institute (NCI)NIH | 1 | Dec 11, 2013 | clinicaltrials |
| NCT00043121 | Combination Chemotherapy in Treating Patients With Advanced Cancer That is Metastatic or Cannot Be Removed By Surgery | completed | Phase 1 | 50 | National Cancer Institute (NCI)NIH | 1 | Dec 11, 2013 | clinicaltrials |
| NCT00103220 | SJG-136 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 1 | Dec 11, 2013 | clinicaltrials |
| NCT00031681 | 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) | completed | Phase 1 | 41 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00138177 | Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors | completed | Phase 1 | 54 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00293345 | 3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00060151 | GW786034 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Case Comprehensive Cancer CenterOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00387504 | Fenretinide in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors | completed | Phase 1 | 21 | California Cancer ConsortiumNETWORK | 1 | Sep 12, 2013 | clinicaltrials |
| NCT00002939 | Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer | completed | Phase 1 | 21 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00003108 | Cisplatin Plus Bryostatin 1 in Treating Patients With Advanced Cancer | completed | Phase 1 | — | Lombardi Comprehensive Cancer CenterOTHER | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00004213 | 3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone in Treating Patients With Solid Tumors | completed | Phase 1 | — | Vion PharmaceuticalsINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00004216 | VNP20009 in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Therapy | completed | Phase 1 | — | Vion PharmaceuticalsINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00006218 | 3-AP in Treating Patients With Advanced Cancer | completed | Phase 1 | — | Vion PharmaceuticalsINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00006254 | VNP20009 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Vion PharmaceuticalsINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00016874 | 3-AP Plus Cisplatin and Paclitaxel in Treating Patients With Advanced or Metastatic Cancer | completed | Phase 1 | — | Vion PharmaceuticalsINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00024323 | Combination Chemotherapy in Treating Patients With Advanced Cancer | completed | Phase 1 | — | Vion PharmaceuticalsINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00025129 | VNP40101M in Treating Patients With Advanced Solid Tumors or Lymphomas | completed | Phase 1 | — | Vion PharmaceuticalsINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00049699 | VNP40101M in Treating Patients With Advanced or Metastatic Cancer | completed | Phase 1 | — | Vion PharmaceuticalsINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00562380 | AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma | completed | Phase 1 | 64 | AmgenINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00005021 | Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or Lymphoma | completed | Phase 1 | 17 | Fox Chase Cancer CenterOTHER | 1 | Jul 11, 2013 | clinicaltrials |
| NCT00004090 | Gemcitabine and Cisplatin in Treating Patients With Metastatic or Recurrent Solid Tumors | completed | Phase 1 | — | Northwestern UniversityOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00045318 | Exatecan Mesylate in Treating Patients With Advanced Solid Tumors and Kidney Dysfunction | completed | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00003103 | Chemotherapy in Treating Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 57 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00072436 | Gemcitabine Hydrochloride and Alvocidib in Treating Patients With Solid Tumors | completed | Phase 1 | 58 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00331955 | Vorinostat and Doxorubicin in Treating Patients With Metastatic or Locally Advanced Solid Tumors | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00036777 | UCN-01 and Carboplatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Jul 1, 2013 | clinicaltrials |
| NCT00003198 | Ifosfamide and Topotecan in Treating Patients With Refractory Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 27, 2013 | clinicaltrials |
| NCT00003197 | Green Tea Extract in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 30 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00003555 | Paclitaxel Plus Chemoprotection With Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors | completed | Phase 1 | 20 | State University of New York - Upstate Medical UniversityOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00003969 | Geldanamycin Analogue in Treating Patients With Advanced Cancer | completed | Phase 1 | — | Cancer Research UKOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00004881 | Vaccine Therapy in Treating Patients With Advanced Cancer | completed | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00024245 | 10-Propargyl-10-Deazaaminopterin Plus Probenecid in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
Data updated 24 days agoSource updated Jan 13, 2014source: clinicaltrials